XT
AXSM icon

XTX Topco’s Axsome Therapeutics AXSM Stock Holding History

XTX Topco’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.55M Buy
18,575
+15,278
+463% +$3.31M 0.06% 434
2026
Q1 		$557K Sell
3,297
-28,557
-90% -$4.93M 0.01% 1942
2025
Q4 		$5.82M Buy
31,854
+30,015
+1,632% +$4.19M 0.15% 94
2025
Q3 		$223K Buy
+1,839
New +$207K 0.01% 1757
2025
Q2 		– Sell
-3,357
Closed -$392K – 2355
2025
Q1 		$392K Sell
3,357
-9,794
-74% -$1.12M 0.02% 1211
2024
Q4 		$1.11M Buy
+13,151
New +$1.21M 0.09% 239
2024
Q3 		– Sell
-11,205
Closed -$902K – 2083
2024
Q2 		$902K Buy
11,205
+7,173
+178% +$531K 0.08% 396
2024
Q1 		$322K Buy
+4,032
New +$338K 0.04% 793
2023
Q4 		– Sell
-4,388
Closed -$307K – 1588
2023
Q3 		$307K Buy
4,388
+1,520
+53% +$114K 0.05% 716
2023
Q2 		$206K Buy
+2,868
New +$212K 0.04% 981
2022
Q4 		– Sell
-6,812
Closed -$304K – 1120
2022
Q3 		$304K Buy
+6,812
New +$340K 0.08% 490
2021
Q2 		– Sell
-4,680
Closed -$265K – 806
2021
Q1 		$265K Buy
+4,680
New +$329K 0.13% 341

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

XTX Topco's AXSM Position: Q2 2026 in Review

XTX Topco increased its Axsome Therapeutics (AXSM) stake by 463% in Q2 2026, buying an estimated $3.31M and bringing the position to 18,575 shares worth $4.55M. The position accounts for 0.06% of the portfolio, ranked #434.

XTX Topco first reported a position in AXSM in Q1 2021 and has held it in 12 quarters since. The position peaked at $5.82M in Q4 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • XTX Topco held 18,575 shares of Axsome Therapeutics worth $4.55M as of Q2 2026.
  • XTX Topco bought 15,278 Axsome Therapeutics shares in Q2 2026, an estimated $3.31M.
  • Axsome Therapeutics made up 0.06% of XTX Topco's portfolio in Q2 2026, its #434 holding.
  • XTX Topco first reported a position in Axsome Therapeutics in Q1 2021 and has held it in 12 quarters since.
  • XTX Topco's Axsome Therapeutics position peaked at $5.82M in Q4 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.